Science Explorer Interactive view Map
Company · King of Prussia · United States

CSL (United States)

In research, CSL (United States) stands highest in Health Sciences (#8,008 of 20,462 worldwide) and Medicine (#7,664 of 17,978 worldwide), over all time.

cslbehring-us.comROR OpenAlex
World rank, 2022–2025
#17,640
of 28,054 · #14,134 all time
Rank in United States
#2,530
of 4,192
Research works
302
▼ 3% vs 2013–17
Citations
9.7k
32.2 per fractional work
Top-10% rate
17.8%
record average 16.5%
Open access
45%
world 28%

What is CSL (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #8,008 of 20,462 18.7%175
MedicineField #7,664 of 17,978 18.5%164

Each strip is that field’s whole ranked pool, with the notch where CSL (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.99× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.06× its world share, 3 worksImmunology and Micro…Neuroscience: 0.51× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.74× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.03× its world share, 0 worksChemistryComputer Science: 0.46× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.17× its world share, 0 worksEarth and Planetary …Engineering: 0.24× its world share, 2 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMathematics: 2.01× its world share, 2 worksMathematicsPhysics and Astronomy: 0.43× its world share, 1 worksPhysics and AstronomyDentistry: 0.18× its world share, 0 worksDentistryHealth Professions: 0.72× its world share, 1 worksHealth ProfessionsMedicine: 3.33× its world share, 41 worksMedicineNursing: 0.45× its world share, 0 worksNursingArts and Humanities: 0.09× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.34× its world share, 1 worksBusiness, Management…Decision Sciences: 1.27× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 1.23× its world share, 2 worksEconomics, Econometr…Psychology: 0.18× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.1×. Every wedge is a field page.

Who are the top researchers at CSL (United States)?

Ranked on the composite score, Jonathan M. Edelman and Mikhail Rojavin lead among researchers whose main affiliation is CSL (United States).

  1. 1 Jonathan M. Edelman United States · #460,111 worldwide 71 citations · 22 works
  2. 2 Mikhail Rojavin United States · #1,127,168 worldwide 10 citations · 18 works
All ranked researchers at CSL (United States)

Which keywords describe research at CSL (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Gene Therapy, Inhibitors, Prophylaxis, Recombinant Factor VIIa, Safety, Factor VIII, Hemophilia and Thrombosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy7▲ 58×3 topics
  2. Inhibitors5▲ 205×3 topics
  3. Prophylaxis5▲ 65×3 topics
  4. Recombinant Factor VIIa5▲ 184×2 topics
  5. Safety5▲ 338×2 topics
  6. Factor VIII5▲ 552×1 topic
  7. Hemophilia5▲ 552×1 topic
  8. Thrombosis5▲ 27×7 topics
  9. Cardiovascular Disease4▲ 5.9×15 topics
  10. Inflammation4▲ 3.0×18 topics
  11. Heart Failure3▲ 11×9 topics
  12. Diagnosis3▲ 4.7×9 topics
  13. Hereditary Angioedema3▲ 223×1 topic
  14. Kinin Receptor Family3▲ 223×1 topic
  15. Quality of Life2▲ 2.7×7 topics
  16. Cardiovascular Disease Prevention2▲ 43×2 topics
  17. Obesity2▲ 4.9×7 topics
  18. Metabolic Syndrome2▲ 4.2×8 topics
  19. Atherosclerosis2▲ 12×6 topics
  20. Diabetes2▲ 6.6×7 topics
  21. Hemostasis2▲ 35×3 topics
  22. Guidelines2▲ 6.6×7 topics
  23. Chronic Disease Management2▲ 15×5 topics
  24. AAV2▲ 72×1 topic
  25. Cholesterol2▲ 20×3 topics
  26. Insulin Resistance2▲ 6.3×4 topics
  27. Viral Vectors2▲ 72×1 topic
  28. Health Outcomes2▲ 9.5×3 topics
  29. Monoclonal Antibodies2▲ 30×3 topics
  30. Medication Adherence2▲ 46×2 topics
  31. Platelets2▲ 37×2 topics
  32. Vascular Biology2▲ 57×2 topics
  33. Anemia2▲ 24×4 topics
  34. Immune Thrombocytopenic Purpura2▲ 91×1 topic
  35. von Willebrand Disease2▲ 91×1 topic
  36. Autoantibodies1▲ 9.4×7 topics
  37. C-Reactive Protein1▲ 30×2 topics
  38. Lifestyle Intervention1▲ 26×2 topics
  39. Patient Compliance1▲ 82×1 topic
  40. Type 2 Diabetes1▲ 9.9×3 topics

Which research topics does CSL (United States) publish most on?

By volume in 2022–2025: Hemophilia Treatment and Research, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Virus-based gene therapy research and Platelet Disorders and Treatments.

Hemophilia Treatment and…5Hemophilia Treatment and Research: 5 fractional worksCoagulation, Bradykinin,…3Coagulation, Bradykinin, Polyphosphates, and Angioedema: 3 fractional worksVirus-based gene therapy…2Virus-based gene therapy research: 2 fractional worksPlatelet Disorders and Treatments: 2 fractional worksMedication Adherence and Compliance: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 1 fractional worksImmunodeficiency and Autoimmune Disorders: 1 fractional worksCAR-T cell therapy research: 1 fractional worksLipoproteins and Cardiovascular Health: 1 fractional works
HematologyGeneticsFamily PracticeEconomics and Econometrics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hemophilia Treatment and Research Hematology 5 works
  2. 2 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 3 works
  3. 3 Virus-based gene therapy research Genetics 2 works
  4. 4 Platelet Disorders and Treatments Hematology 2 works
  5. 5 Medication Adherence and Compliance Family Practice 1 works
  6. 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  7. 7 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Immunodeficiency and Autoimmune Disorders Immunology 1 works
  9. 9 CAR-T cell therapy research Oncology 1 works
  10. 10 Lipoproteins and Cardiovascular Health Surgery 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.1%not open54.9%

World: 28% of research is openly available.

with international co-authors40.4%domestic only59.6%

World: 19% is written across borders.

How has CSL (United States)'s research output changed?

Output in 2018–2022 was 3% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in King of Prussia

All research institutions in King of Prussia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.